However, the clinical significance of TMAO generation from L-carnitine supplementation in humans remains under active investigation, and there is currently no official regulatory warning from the MHRA or EMA specifically prohibiting its use on these grounds
The focus here is research-use-only product evaluation: compound identity, COA review, analytical testing, lot traceability, supplier documentation, and careful separation of published literature from product claims
A clinical trial published in the American Journal of Clinical Nutrition found that just 500 milligrams of vitamin C a day leads to an almost 50% increase in levels of red blood cell glutathione
Colorados Prescription Drug Affordability Board (PDAB) voted to allow the state Attorney Generals office to appeal the preliminary injunction against its upper payment limit (UPL) on the arthritis drug Enbrel
A patient who has already been on GLP-1 treatment through a compounding platform, is comfortable with the compounded medication model, and is looking for a continuation of that access pathway as the regulatory environment evolves